ZUMIEZ INC (ZUMZ)
US9898171015 - Common Stock
Taking everything into account, ZUMZ scores 3 out of 10 in our fundamental rating. ZUMZ was compared to 125 industry peers in the Specialty Retail industry. No worries on liquidiy or solvency for ZUMZ as it has an excellent financial health rating, but there are worries on the profitability. ZUMZ does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
ZUMZ had negative earnings in the past year.
ZUMZ had a positive operating cash flow in the past year.
ZUMZ had positive earnings in 4 of the past 5 years.
Of the past 5 years ZUMZ 4 years had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -9.43%, ZUMZ is not doing good in the industry: 69.60% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -17.73%, ZUMZ is in line with its industry, outperforming 40.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.43% | ||
| ROE | -17.73% | ||
| ROIC | N/A |
ROA(3y)2.41%
ROA(5y)4.43%
ROE(3y)4.3%
ROE(5y)8.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 32.09%, ZUMZ is doing worse than 61.60% of the companies in the same industry.
ZUMZ's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ZUMZ so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.09% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-1.25%
2. Health
2.1 Basic Checks
ZUMZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZUMZ has been increased compared to 1 year ago.
Compared to 5 years ago, ZUMZ has less shares outstanding
ZUMZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 2.25 indicates that ZUMZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
ZUMZ has a Altman-Z score of 2.25. This is comparable to the rest of the industry: ZUMZ outperforms 53.60% of its industry peers.
ZUMZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.25 |
ROIC/WACCN/A
WACC9.23%
2.3 Liquidity
ZUMZ has a Current Ratio of 2.27. This indicates that ZUMZ is financially healthy and has no problem in meeting its short term obligations.
ZUMZ has a Current ratio of 2.27. This is amongst the best in the industry. ZUMZ outperforms 86.40% of its industry peers.
ZUMZ has a Quick Ratio of 1.37. This is a normal value and indicates that ZUMZ is financially healthy and should not expect problems in meeting its short term obligations.
ZUMZ has a better Quick ratio (1.37) than 78.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
The earnings per share for ZUMZ have decreased strongly by -398.17% in the last year.
Looking at the last year, ZUMZ shows a decrease in Revenue. The Revenue has decreased by -8.65% in the last year.
Measured over the past years, ZUMZ shows a decrease in Revenue. The Revenue has been decreasing by -2.20% on average per year.
EPS 1Y (TTM)-398.17%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-393.22%
Revenue 1Y (TTM)-8.65%
Revenue growth 3Y-4.04%
Revenue growth 5Y-2.2%
Revenue growth Q2Q0.61%
3.2 Future
Based on estimates for the next years, ZUMZ will show a very strong growth in Earnings Per Share. The EPS will grow by 30.57% on average per year.
The Revenue is expected to grow by 2.30% on average over the next years.
EPS Next Y93.1%
EPS Next 2Y47.13%
EPS Next 3Y30.57%
EPS Next 5YN/A
Revenue Next Year0.38%
Revenue Next 2Y1.82%
Revenue Next 3Y2.3%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ZUMZ. In the last year negative earnings were reported.
Also next year ZUMZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ZUMZ's earnings are expected to grow with 30.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.13%
EPS Next 3Y30.57%
5. Dividend
5.1 Amount
No dividends for ZUMZ!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ZUMIEZ INC
NASDAQ:ZUMZ (4/19/2024, 12:23:09 PM)
15
+0.64 (+4.46%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap297.45M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.43% | ||
| ROE | -17.73% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.09% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-398.17%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y93.1%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-8.65%
Revenue growth 3Y-4.04%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y